Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
MDT holding history
Medtronic plc in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDT overviewAll 13F holders of MDTFull Q2 2026 holdings
- Shares (Q2 2026)
- 71,306
- Value
- $5.58M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 71,306 | $5.58M | <0.1% | +37,753+112.5% | Added | Holders |
| Q1 2026 | 33,553 | $2.91M | <0.1% | −10,987−24.7% | Reduced | Holders |
| Q4 2025 | 44,540 | $4.28M | <0.1% | −6,576−12.9% | Reduced | Holders |
| Q3 2025 | 51,116 | $4.87M | <0.1% | −16,507−24.4% | Reduced | Holders |
| Q2 2025 | 67,623 | $5.89M | <0.1% | −101,319−60.0% | Reduced | Holders |
| Q1 2025 | 168,942 | $15.2M | <0.1% | −46,433−21.6% | Reduced | Holders |
| Q4 2024 | 215,375 | $17.2M | 0.1% | +9,646+4.7% | Added | Holders |
| Q3 2024 | 205,729 | $18.5M | 0.1% | −1,761−0.8% | Reduced | Holders |
| Q2 2024 | 207,490 | $16.3M | 0.1% | +20,712+11.1% | Added | Holders |
| Q1 2024 | 186,778 | $16.3M | 0.1% | +36,507+24.3% | Added | Holders |
| Q4 2023 | 150,271 | $12.4M | 0.1% | +117,598+359.9% | Added | Holders |
| Q3 2023 | 32,673 | $2.56M | <0.1% | −56,673−63.4% | Reduced | Holders |
| Q2 2023 | 89,346 | $7.87M | <0.1% | −2,762,941−96.9% | Reduced | Holders |
| Q1 2023 | 2,852,287 | $230.0M | 1.2% | −13,654−0.5% | Reduced | Holders |
| Q4 2022 | 2,865,941 | $222.7M | 1.2% | −112,811−3.8% | Reduced | Holders |
| Q3 2022 | 2,978,752 | $240.5M | 1.4% | −10,812−0.4% | Reduced | Holders |
| Q2 2022 | 2,989,564 | $268.3M | 1.5% | −121,853−3.9% | Reduced | Holders |
| Q1 2022 | 3,111,417 | $345.2M | 1.7% | −7,732−0.2% | Reduced | Holders |
| Q4 2021 | 3,119,149 | $322.7M | 1.5% | −4,332−0.1% | Reduced | Holders |
| Q3 2021 | 3,123,481 | $391.5M | 1.9% | +142,443+4.8% | Added | Holders |
| Q2 2021 | 2,981,038 | $370.0M | 1.9% | −3260.0% | Reduced | Holders |
| Q1 2021 | 2,981,364 | $352.2M | 1.9% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.